Evidence map›Paper›PMID 31399272›Full record

ArticleJournal of substance abuse treatment2020

Implementation of the hub and spoke model for opioid use disorders in California: Rationale, design and anticipated impact.

Gloria M Miele, Lauren Caton, Thomas E Freese, Mark McGovern, Kendall Darfler, Valerie Pearce Antonini, Marlies Perez, Richard Rawson

Open access · greenAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of substance abuse treatment, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed, 1 pooled it
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Observational
  8. Article
  9. Gene therapy for Duchenne Muscular Dystrophy: assessing the readiness of Italian centres of expertise.Acta myologica : myopathies and cardiomyopathies : official journal of the Mediterranean Society of Myology · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Financial Sustainability of Novel Delivery Models in Behavioral Health Treatment.The journal of mental health policy and economics · 2023
    Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Gloria M MieleUniversity of California, Los Angeles Integrated Substance Abuse Programs, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America; David Geffen School of Medicine at UCLA, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America. Electronic address: gmiele@mednet.ucla.edu.
Lauren CatonStanford University School of Medicine, 1520 Page Mill Road, MC 5265, Palo Alto, CA 94304, United States of America. Electronic address: lauren.caton@stanford.edu.
Thomas E FreeseUniversity of California, Los Angeles Integrated Substance Abuse Programs, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America; David Geffen School of Medicine at UCLA, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America. Electronic address: tfreese@mednet.ucla.edu.
Mark McGovernStanford University School of Medicine, 1520 Page Mill Road, MC 5265, Palo Alto, CA 94304, United States of America. Electronic address: mpmcg@stanford.edu.
Kendall DarflerUniversity of California, Los Angeles Integrated Substance Abuse Programs, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America; David Geffen School of Medicine at UCLA, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America. Electronic address: kdarfler@mednet.ucla.edu.
Valerie Pearce AntoniniUniversity of California, Los Angeles Integrated Substance Abuse Programs, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America; David Geffen School of Medicine at UCLA, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America. Electronic address: vpearce@mednet.ucla.edu.
Marlies PerezCalifornia Department of Health Care Services, 1500 Capitol Ave, Sacramento, CA 95814, United States of America. Electronic address: marlies.perez@dhcs.ca.gov.
Richard RawsonUniversity of California, Los Angeles Integrated Substance Abuse Programs, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America; David Geffen School of Medicine at UCLA, 11075 Santa Monica Blvd., #200, Los Angeles, CA 90025, United States of America; Center for Behavior and Health, University of Vermont, 1 So Prospect Street, Burlington, VT 05405, United States of America. Electronic address: rrawson@mednet.ucla.edu.
University of California, Los Angeles · USOASIS Clinic · USStanford University · USCalifornia Department of Health Care Services · US

Funding

Vermont Center on Behavior and HealthP20GM103644 · NIGMS · UNIVERSITY OF VERMONT & ST AGRIC COLLEGE · PI KHADANGA, SHERRIE · 2013 to 2022
$21.3M
NIGMS NIH HHS P20 GM103644
6 · The paper itself

Abstract

As part of the State Targeted Response to the opioid epidemic, California has adopted the Hub and Spoke model to expand access to medications for opioid use disorder, particularly buprenorphine, throughout the state. By aligning opioid treatment programs as hubs with primary care, office-based practitioners, and other health care settings as spokes, a broader treatment model can reach more people with opioid use disorder, improve access to medications for opioid use disorders, and decrease overdose deaths. Expanding access requires expanding knowledge and intensive implementation support of new practices. This paper describes the rationale, specific activities and anticipated impact of the implementation plan in California's Hub and Spoke system. Training and technical assistance are designed to: increase the number and capacity of waivered prescribers; enhance skills of prescribers and multidisciplinary teams; and create systems change. Activities include buprenorphine waiver trainings and provider support, a practice facilitator program, Project ECHO sessions, webinars, clinical skills trainings, and regional learning collaboratives. This overview highlights the steps California is taking to build treatment capacity to address the opioid epidemic.

Indexed as

Health Plan ImplementationAnalgesics, OpioidBuprenorphineCaliforniaGovernment ProgramsHealth Services AccessibilityHumansOpiate Substitution TreatmentOpioid-Related DisordersPrimary Health CareState GovernmentAnalgesics, OpioidBuprenorphineBuprenorphineCalifornia state targeted responseImplementationOpioid epidemicOpioid use disorder treatment

Identifiers

PMID31399272
PMCPMC6893120
OpenAlexW2964453389

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.